Impairing Drugs and Alcohol as Risk Factors for Traumatic Injuries
IDART
1 other identifier
observational
5,000
1 country
1
Brief Summary
Impairing drugs and alcohol are major risk factors for traumatic injuries. Still there is to date little knowledge to what extent these factors affect the epidemiology of trauma. Detailed mapping of risk factors improve targeting and efficiency of primary injury prevention. The aim of this project is therefore to facilitate injury prevention through improved data collection and analysis on impairing drugs and alcohol as a contributing and modifiable factor in injury morbidity and mortality. Study question: What is the toxicological profile among patients with suspected severe traumatic injury? Study design: a prospective population-based and national observational study will analyse toxicology from blood samples of all trauma admission during a 12 month study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2018
CompletedFirst Posted
Study publicly available on registry
December 12, 2018
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 29, 2020
CompletedJune 21, 2021
June 1, 2021
1 year
June 10, 2018
June 18, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Presence of alcohol in blood samples.
Alcohol is reported in grams per liter. Analysis of alcohol is performed with an automated enzymatic method using alcohol dehydrogenase.
Blood sample are collected at time of hospital admission for each participant. There is only one sample taken from each participant. Samples are consecutively analyzed during the study period. The database is analyzed after study period is completed.
Presence of impairing illicit and medicinal drugs in blood samples.
Impairing substances are reported as nanogram per milliliter. Analysis is performed using liquid chromatography coupled with mass spectrometry.
Blood sample are collected at time of hospital admission for each participant. There is only one sample taken from each participant. Samples are consecutively analyzed during the study period.
Eligibility Criteria
All trauma patients received by trauma team at any Norwegian trauma hospital during the study period.
You may qualify if:
- admission to any Norwegian Trauma Hospital (n=37) AND trauma team activation, during study period
You may not qualify if:
- age
- foreign citizens
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- University of Oslocollaborator
- Norwegian National Trauma Registrycollaborator
- Norwegian National Advisory Unit on Traumacollaborator
- Norwegian Public Roads Administrationcollaborator
- Norwegian Directorate of Healthcollaborator
- Norwegian Ministry of Transport and Communicationscollaborator
- Sykehuset Innlandet HFcollaborator
Study Sites (1)
OsloUH
Oslo, 0372, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 10, 2018
First Posted
December 12, 2018
Study Start
March 1, 2019
Primary Completion
February 29, 2020
Study Completion
February 29, 2020
Last Updated
June 21, 2021
Record last verified: 2021-06